您当前的位置:
首页 >
文章列表页 >
Site-specific development and preclinical evaluation of 68Ga-THP-ACN376, a CLDN18.2-targeted nanobody probe
更新时间:2025-12-15
    • Site-specific development and preclinical evaluation of 68Ga-THP-ACN376, a CLDN18.2-targeted nanobody probe

    • Oncoradiology   Vol. 34, Issue 5, Pages: 470-476(2025)
    • DOI:10.19732/j.cnki.2096-6210.2025.05.005    

      CLC:
    • Received:24 September 2025,

      Online First:06 November 2025,

      Published:28 October 2025

    移动端阅览

  • Chang LIU, Yuwen YANG, Zhi YANG, et al. Site-specific development and preclinical evaluation of 68Ga-THP-ACN376, a CLDN18.2-targeted nanobody probe[J]. Oncoradiology, 2025, 34(5): 470-476. DOI: 10.19732/j.cnki.2096-6210.2025.05.005. DOI:

  •  
  •  

0

Views

117

下载量

0

CNKI被引量

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

In vitro and in vivo evaluation of targeted probe 68 Ga-NOTA-376 constructed by non-site-specific labeling method for CLDN18.2
Head-to-head comparative study of 18F-FDG and 18F-FMISO PET/CT in guiding carbon ion radiotherapy for patients with locally advanced non-small cell lung cancer
Computer-aided design of a novel HER2-targeted cyclic peptide PET probe and its evaluation for noninvasive imaging of breast cancer
Prediction of lymphovascular invasion using multiparametric MRI habitat radiomics based on machine learning algorithms in gastric cancer
A comparative study of 68Ga-TBM-001 PET/CT and 99mTc-MDP bone scintigraphy in the diagnosis of bone metastases of prostate cancer

Related Author

LIU Chang
CHEN Yan
LI Dapeng
YANG Zhi
ZHU Hua
CHENG Jingyi
REN Caiyue
ZHANG Jiangang

Related Institution

College of Materials Science and Engineering, Beijing University of Technology
Guizhou University Medicine College
Department of Nuclear Medicine, Peking&nbsp
Department of Radiotherapy, Shanghai Proton and Heavy Ion Center, Fudan University Shanghai Cancer Center
Department of Nuclear Medicine, Shanghai Proton and Heavy Ion Center, Fudan University Shanghai Cancer Center
0